Shawn O'Brien
Chief Executive Officer chez MAYNE PHARMA GROUP LIMITED
Fortune : 174 959 $ au 31/03/2024
Profil
Shawn Patrick O'Brien was the founder of AltheRx, Inc. founded in 2010, where he held the title of President, Chief Executive Officer & Director until 2013.
Currently, he is the Chief Executive Officer, Director & MD at Mayne Pharma Group Ltd.
since 2022.
He is also the Chairman at Alto Pharmaceuticals Ltd.
and Non-Executive Chairman at SFA Therapeutics, Inc. He was also the Director at Crozer-Keystone Health System from 2008 to 2016, Director at Melanovus Oncology, Inc. in 2013-2014, President at Cipher Pharmaceuticals, Inc. from 2016 to 2017, Vice President-Commercial Operations at AstraZeneca Pharmaceuticals LP in 2004, and Principal at The Upjohn Co. He received his undergraduate degree from the University of Western Ontario.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MAYNE PHARMA GROUP LTD.
0,04% | 08/12/2023 | 37 041 ( 0,04% ) | 174 959 $ | 31/03/2024 |
Postes actifs de Shawn O'Brien
| Sociétés | Poste | Début |
|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Chief Executive Officer | 01/10/2022 |
Alto Pharmaceuticals Ltd.
 Alto Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Alto Pharmaceuticals Ltd. Develops and commercialize products for maintaining a healthy lifestyle and improving quality of life. The firm’s area of interest includes dermatology and skin care, as well as post surgical support. The company was founded by Joan Chypyha in 2008 and is headquartered in Oakridges, Canada. | Chairman | - |
SFA Therapeutics, Inc.
 SFA Therapeutics, Inc. Packaged SoftwareTechnology Services SFA Therapeutics, Inc. is a clinical-stage biotech company based on breakthrough research of the human microbiome licensed from Temple University. SFA Therapeutics is located in Jenkintown, PA. Ira Spector has been the CEO of the company since 2017. The company is developing a platform of safer therapeutics focused on the treatment of inflammatory diseases, targeting NF-kB and RAS. SFA has identified six small molecule drug candidates from this platform, including its lead asset, SFA-002, which has shown promising phase 1a results and is currently being investigated in a phase 1b study for psoriasis. The company's research program is focused on the intersection of chronic inflammation and cancer. | Chairman | - |
Anciens postes connus de Shawn O'Brien
| Sociétés | Poste | Fin |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Chief Executive Officer | 11/11/2016 |
Crozer-Keystone Health System
 Crozer-Keystone Health System Medical/Nursing ServicesHealth Services Crozer-Keystone Health System provides full spectrum of wellness, prevention, acute care, rehabilitation and restorative care to the community. It services includes a Level 2 trauma center; a regional burn center; three regional cancer centers affiliated with Fox Chase Cancer Center; a fertility center; sleep-disorders centers; wound care centers with hyperbaric medicine; comprehensive maternity services, including intensive care nurseries and maternal fetal medicine; a kidney transplant center; advanced heart care services, including open heart surgery; orthopedic services, sports medicine and physical therapy and rehabilitation services; senior health services; a bariatric surgery program; medical imaging services; and a comprehensive physician network of primary-care and specialty practices. The company was founded in 1990 and is headquartered in Springfield, PA. | Director/Board Member | 01/06/2016 |
Melanovus Oncology, Inc.
 Melanovus Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Melanovus Oncology, Inc. provides laboratory testing services. It focuses on discovering, developing and commercializing new therapeutics, diagnostics and topically delivered compounds for late stage melanoma and other skin cancers. The company was founded in 2012 and is headquartered in Jensen Beach, FL. | Director/Board Member | 01/12/2014 |
Altherx, Inc.
 Altherx, Inc. Medical/Nursing ServicesHealth Services Altherx, Inc. operates as a clinical development company. The company was founded on May 11, 2010 and is headquartered in Glenmoore, PA. | Founder | 01/02/2013 |
Profectus BioSciences, Inc.
 Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Chief Executive Officer | 01/01/2010 |
Formation de Shawn O'Brien
| University of Western Ontario | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| MAYNE PHARMA GROUP LIMITED | Health Technology |
| Entreprise privées | 11 |
|---|---|
| The Upjohn Co. | Health Technology |
Solstice Neurosciences, Inc.
 Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Solstice Neurosciences, Inc. was a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. The company was founded in 2004 and is headquartered in Malvern, PA. | Health Technology |
Crozer-Keystone Health System
Crozer-Keystone Health System Medical/Nursing ServicesHealth Services Crozer-Keystone Health System provides full spectrum of wellness, prevention, acute care, rehabilitation and restorative care to the community. It services includes a Level 2 trauma center; a regional burn center; three regional cancer centers affiliated with Fox Chase Cancer Center; a fertility center; sleep-disorders centers; wound care centers with hyperbaric medicine; comprehensive maternity services, including intensive care nurseries and maternal fetal medicine; a kidney transplant center; advanced heart care services, including open heart surgery; orthopedic services, sports medicine and physical therapy and rehabilitation services; senior health services; a bariatric surgery program; medical imaging services; and a comprehensive physician network of primary-care and specialty practices. The company was founded in 1990 and is headquartered in Springfield, PA. | Health Services |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Health Technology |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Altherx, Inc.
Altherx, Inc. Medical/Nursing ServicesHealth Services Altherx, Inc. operates as a clinical development company. The company was founded on May 11, 2010 and is headquartered in Glenmoore, PA. | Health Services |
Genomind, Inc.
 Genomind, Inc. Medical/Nursing ServicesHealth Services Genomind, Inc. provides molecular diagnostics services. Its changes the trial-and-error approach to treatment planning in psychiatry today and helps clinicians find more effective treatments based on the patient’s genetic profile. The company was founded by Jay L. Lombard and Ronald I. Dozoretz in 2009 and is headquartered in King of Prussia, PA. | Health Services |
Melanovus Oncology, Inc.
Melanovus Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Melanovus Oncology, Inc. provides laboratory testing services. It focuses on discovering, developing and commercializing new therapeutics, diagnostics and topically delivered compounds for late stage melanoma and other skin cancers. The company was founded in 2012 and is headquartered in Jensen Beach, FL. | Commercial Services |
SFA Therapeutics, Inc.
SFA Therapeutics, Inc. Packaged SoftwareTechnology Services SFA Therapeutics, Inc. is a clinical-stage biotech company based on breakthrough research of the human microbiome licensed from Temple University. SFA Therapeutics is located in Jenkintown, PA. Ira Spector has been the CEO of the company since 2017. The company is developing a platform of safer therapeutics focused on the treatment of inflammatory diseases, targeting NF-kB and RAS. SFA has identified six small molecule drug candidates from this platform, including its lead asset, SFA-002, which has shown promising phase 1a results and is currently being investigated in a phase 1b study for psoriasis. The company's research program is focused on the intersection of chronic inflammation and cancer. | Technology Services |
| Cyrano LLC | |
Alto Pharmaceuticals Ltd.
Alto Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Alto Pharmaceuticals Ltd. Develops and commercialize products for maintaining a healthy lifestyle and improving quality of life. The firm’s area of interest includes dermatology and skin care, as well as post surgical support. The company was founded by Joan Chypyha in 2008 and is headquartered in Oakridges, Canada. | Health Technology |
